Executive Director, Myeloma Canada

Starting her career in clinical research in the pharmaceutical industry, Martine has dedicated her career to helping patients get access to innovative medical treatments. She is a strong believer in ensuring the patient voice is included in all aspects of health policy decisions. Her role at Myeloma Canada is to develop, lead and execute all advocacy strategies and programs for Myeloma Canada and support the Board of Directors in its goals of shaping access to new therapies and strengthening the Myeloma Canada patient and caregiver community across Canada.

In her most recent position, Martine was the Director, National Patient Engagement Strategy at JANSSEN Inc., with responsibilities for developing and executing an industry-leading national patient engagement strategy. Her main objective was to champion patient advocacy and improve patient access to medications. At the same time, she was also part of an international advocacy team working on a global patient advocacy strategy that engaged with patient groups in various countries around the world. As a recognized industry leader in patient advocacy, Martine was invited to be the Vice-Chair of Rx&D’s (now IMC) Stakeholder Strategic Advisory Team. Under her leadership, the committee’s role was to advise the Rx&D Board on strategic stakeholder relationship initiatives and best practices. Martine has a B.Sc. in Biology from the Université de Montréal and a M.Sc. in Marine Mammal Biology from the University of Guelph.